Kennondale Capital Management LLC acquired a new stake in shares of Plexus Corp. (NASDAQ:PLXS - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 8,809 shares of the technology company's stock, valued at approximately $1,378,000. Plexus accounts for approximately 1.1% of Kennondale Capital Management LLC's holdings, making the stock its 23rd largest position.
Several other large investors also recently added to or reduced their stakes in PLXS. Pacer Advisors Inc. purchased a new stake in Plexus during the fourth quarter valued at about $107,489,000. Raymond James Financial Inc. purchased a new stake in Plexus during the fourth quarter valued at about $15,892,000. Disciplined Growth Investors Inc. MN raised its position in Plexus by 2.8% during the third quarter. Disciplined Growth Investors Inc. MN now owns 2,168,512 shares of the technology company's stock valued at $296,457,000 after purchasing an additional 59,465 shares in the last quarter. Algert Global LLC raised its position in Plexus by 1,546.5% during the third quarter. Algert Global LLC now owns 45,790 shares of the technology company's stock valued at $6,260,000 after purchasing an additional 43,009 shares in the last quarter. Finally, Barclays PLC raised its position in Plexus by 139.4% during the third quarter. Barclays PLC now owns 48,786 shares of the technology company's stock valued at $6,669,000 after purchasing an additional 28,406 shares in the last quarter. Institutional investors own 94.45% of the company's stock.
Insider Buying and Selling
In related news, CAO Angelo Michael Ninivaggi, Jr. sold 3,423 shares of the business's stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $145.14, for a total value of $496,814.22. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $4,281,775.14. The trade was a 10.40 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Michael J. Running sold 1,250 shares of the business's stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $138.62, for a total transaction of $173,275.00. Following the completion of the transaction, the insider now owns 1,276 shares of the company's stock, valued at approximately $176,879.12. The trade was a 49.49 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 19,458 shares of company stock valued at $2,786,515 over the last ninety days. 1.76% of the stock is owned by insiders.
Analyst Ratings Changes
Several research firms have recently commented on PLXS. Benchmark reiterated a "buy" rating and issued a $165.00 price objective on shares of Plexus in a report on Wednesday, January 22nd. Needham & Company LLC lifted their price objective on Plexus from $162.00 to $172.00 and gave the stock a "buy" rating in a report on Friday, January 24th. Finally, Stifel Nicolaus began coverage on Plexus in a report on Tuesday, February 4th. They issued a "hold" rating and a $152.00 price objective on the stock. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $163.00.
Read Our Latest Analysis on PLXS
Plexus Trading Down 0.7 %
Shares of NASDAQ PLXS traded down $0.88 during trading hours on Friday, hitting $128.21. The company's stock had a trading volume of 743,463 shares, compared to its average volume of 151,233. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.70 and a current ratio of 1.53. The stock has a market cap of $3.47 billion, a price-to-earnings ratio of 29.75 and a beta of 0.90. Plexus Corp. has a 12 month low of $90.87 and a 12 month high of $172.89. The business has a 50-day simple moving average of $140.08 and a 200-day simple moving average of $145.39.
Plexus (NASDAQ:PLXS - Get Free Report) last posted its earnings results on Wednesday, January 22nd. The technology company reported $1.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.59 by ($0.10). Plexus had a return on equity of 10.36% and a net margin of 3.03%. On average, analysts anticipate that Plexus Corp. will post 5.9 earnings per share for the current fiscal year.
Plexus Company Profile
(
Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Featured Stories

Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.